| RS2467778285 |
GLI2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2467778927 |
GLI2
|
Health Risk |
Pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS2467786089 |
GLI2
|
Health Risk |
Likely pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS2467811607 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS2467827 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Congenital hypothyroidism |
| RS2467828 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS2467829 |
DUOX2;DUOXA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS2467829039 |
EXOC6B
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia with joint laxity, type 3 |
| RS2467829103 |
KYNU
|
Health Risk |
Pathogenic |
Vertebral, cardiac |
| RS2467830 |
DUOX2;DUOXA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS2467838286 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2467838766 |
SCN2A
|
Health Risk |
Pathogenic |
Non-syndromic intellectual disability, Non-syndromic intellectual disability |
| RS2467839682 |
KYNU
|
Health Risk |
Likely pathogenic |
KYNU-related disorder, KYNU-related disorder |
| RS2467844829 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2467855307 |
GALNT3
|
Health Risk |
Pathogenic |
— |
| RS2467861939 |
GALNT3
|
Health Risk |
Likely pathogenic |
— |
| RS2467862069 |
GALNT3
|
Health Risk |
Pathogenic |
— |
| RS2467866387 |
GALNT3
|
Health Risk |
Pathogenic |
— |
| RS2467866643 |
ORC4
|
Health Risk |
Pathogenic |
— |
| RS2467867016 |
GALNT3
|
Health Risk |
Pathogenic |
— |
| RS2467868320 |
SCN9A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS2467868574 |
SCN9A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS2467868979 |
SCN9A
|
Health Risk |
Pathogenic |
Channelopathy-associated congenital insensitivity to pain, autosomal recessive |
| RS2467869449 |
GALNT3
|
Health Risk |
Pathogenic |
— |
| RS2467869522 |
GALNT3
|
Health Risk |
Pathogenic |
— |
| RS2467869707 |
GALNT3
|
Health Risk |
Pathogenic |
— |
| RS2467871068 |
GALNT3
|
Health Risk |
Pathogenic |
— |
| RS2467871379 |
GALNT3
|
Health Risk |
Likely pathogenic |
— |
| RS2467875330 |
GALNT3
|
Health Risk |
Likely pathogenic |
— |
| RS2467875895 |
GALNT3
|
Health Risk |
Pathogenic |
— |
| RS2467880808 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2467880827 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2467884030 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS2467886070 |
SCN2A
|
Health Risk |
Likely pathogenic |
SCN2A-related disorder, SCN2A-related disorder |
| RS2467886849 |
SCN2A
|
Health Risk |
Likely pathogenic |
SCN2A-related disorder, SCN2A-related disorder |
| RS2467887062 |
SCN2A
|
Health Risk |
Likely pathogenic |
SCN2A-related disorder, SCN2A-related disorder |
| RS2467889965 |
GALNT3
|
Health Risk |
Pathogenic/Likely pathogenic |
Tumoral calcinosis, hyperphosphatemic |
| RS2467890125 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS2467890178 |
SCN2A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Seizures |
| RS2467890286 |
SCN2A
|
Health Risk |
Likely pathogenic |
SCN2A-related disorder, SCN2A-related disorder |
| RS2467890308 |
GALNT3
|
Health Risk |
Pathogenic |
— |
| RS2467890325 |
SCN2A
|
Health Risk |
Likely pathogenic |
Episodic ataxia, type 9 |
| RS2467890450 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2467890573 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2467895421 |
SCN2A
|
Health Risk |
Likely pathogenic |
SCN2A-related disorder, SCN2A-related disorder |
| RS2467895577 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2467901322 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2467902376 |
SCN2A
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, infantile or early childhood |
| RS2467902405 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2467902634 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2467908837 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2467909264 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2467933218 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2467933285 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2467933702 |
SCN2A
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2467933997 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2467934185 |
SCN2A
|
Health Risk |
Likely pathogenic |
Episodic ataxia, type 9 |
| RS2467934367 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2467934415 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2467946472 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2467961545 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2467961829 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2467961957 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2467962097 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS2467962102 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2467962268 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2467982175 |
SCN9A
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS2467986204 |
SCN9A
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS2467990507 |
BUB1
|
Health Risk |
Pathogenic |
Microcephaly 30, primary |
| RS2467999094 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2467999221 |
SCN2A
|
Health Risk |
Likely pathogenic |
SCN2A-related disorder, SCN2A-related disorder |
| RS2467999322 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2468003378 |
SCN9A
|
Health Risk |
Likely pathogenic |
Primary erythromelalgia, Primary erythromelalgia |
| RS2468007402 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468007693 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468008210 |
SCN2A
|
Health Risk |
Likely pathogenic |
SCN2A-related disorder, SCN2A-related disorder |
| RS2468008251 |
SCN2A
|
Health Risk |
Likely pathogenic |
Infantile spasms, Infantile spasms |
| RS2468008256 |
SCN2A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2468008587 |
SCN2A
|
Health Risk |
Likely pathogenic |
Epilepsy of infancy with migrating focal seizures, Epilepsy of infancy with migrating focal seizures |
| RS2468008617 |
ORC4
|
Health Risk |
Pathogenic |
— |
| RS2468008621 |
SCN2A
|
Health Risk |
Likely pathogenic |
benign sporadic neonatal-infantile epilepsy, benign sporadic neonatal-infantile epilepsy |
| RS2468009874 |
KYNU
|
Health Risk |
Pathogenic |
— |
| RS2468017329 |
BUB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2468019480 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS2468024409 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS2468024864 |
SCN9A
|
Health Risk |
Likely pathogenic |
Channelopathy-associated congenital insensitivity to pain, autosomal recessive |
| RS2468033187 |
BBS5
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2468033258 |
BBS5
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 5, Bardet-Biedl syndrome 5 |
| RS2468034593 |
SCN9A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS2468035550 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2468035572 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2468035584 |
SCN2A
|
Health Risk |
Likely pathogenic |
SCN2A-related disorder, SCN2A-related disorder |
| RS2468035649 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468036301 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2468036514 |
BBS5
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2468036567 |
BBS5
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2468037280 |
BBS5
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2468039380 |
SCN9A
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS2468039852 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS2468040256 |
ERCC3
|
Health Risk |
Pathogenic |
— |